{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T01:14:41Z","timestamp":1774142081655,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,25]],"date-time":"2011-05-25T00:00:00Z","timestamp":1306281600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1745-6215-12-134","type":"journal-article","created":{"date-parts":[[2011,5,25]],"date-time":"2011-05-25T18:22:09Z","timestamp":1306347729000},"source":"Crossref","is-referenced-by-count":8,"title":["Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication"],"prefix":"10.1186","volume":"12","author":[{"given":"Roger J","family":"Lewis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason T","family":"Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R","family":"Teerlink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie T","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R","family":"Hiatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric P","family":"Brass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,25]]},"reference":[{"key":"672_CR1","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.jacc.2007.11.077","volume":"51","author":"GM Welten","year":"2008","unstructured":"Welten GM, Schouten O, Hoeks SE: Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease. J Am Coll Cardiol. 2008, 51: 1588-96. 10.1016\/j.jacc.2007.11.077.","journal-title":"J Am Coll Cardiol"},{"key":"672_CR2","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","volume":"297","author":"PG Steg","year":"2007","unstructured":"Steg PG, Bhatt DL, Wilson PW: One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007, 297: 1197-206. 10.1001\/jama.297.11.1197.","journal-title":"JAMA"},{"key":"672_CR3","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","volume":"286","author":"AT Hirsch","year":"2001","unstructured":"Hirsch AT, Criqui MH, Treat-Jacobson D: Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001, 286: 1317-24. 10.1001\/jama.286.11.1317.","journal-title":"JAMA"},{"key":"672_CR4","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.jacc.2005.10.009","volume":"47","author":"AT Hirsch","year":"2006","unstructured":"Hirsch AT, Haskal ZJ, Hertzer NR: ACC\/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery\/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC\/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006, 47: 1239-312. 10.1016\/j.jacc.2005.10.009.","journal-title":"J Am Coll Cardiol"},{"key":"672_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/1358863X10361545","volume":"15","author":"RL Pande","year":"2010","unstructured":"Pande RL, Hiatt WR, Zhang P, Hittel N, Creager MA, McDermott M: A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication. Vasc Med. 2010, 15: 181-8. 10.1177\/1358863X10361545.","journal-title":"Vasc Med"},{"key":"672_CR6","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1016\/j.jacc.2006.07.064","volume":"48","author":"EP Brass","year":"2006","unstructured":"Brass EP, Anthony R, Cobb FR, Koda I, Jiao J, Hiatt WR: The novel phosphodiesterase inhibitor NM-702 improves claudication-limited exercise performance in patients with peripheral arterial disease. J Am Coll Cardiol. 2006, 48: 2539-45. 10.1016\/j.jacc.2006.07.064.","journal-title":"J Am Coll Cardiol"},{"key":"672_CR7","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","volume":"325","author":"M Packer","year":"1991","unstructured":"Packer M, Carver JR, Rodeheffer RJ: Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 1991, 325: 1468-75. 10.1056\/NEJM199111213252103.","journal-title":"N Engl J Med"},{"key":"672_CR8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/009286150904300503","volume":"43","author":"B Gaydos","year":"2009","unstructured":"Gaydos B, Anderson KM, Berry D: Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development. Drug Information Journal. 2009, 43: 539-56.","journal-title":"Drug Information Journal"},{"key":"672_CR9","unstructured":"Antonijevic Z, Pinheiro J, Fardipour P, Lewis RJ: Impact of Dose Selection Strategies Used in Phase II on the Probability of Success in Phase III. Statistics in Biopharmaceutical Research."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1745-6215-12-134\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-12-134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-12-134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-12-134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T20:11:09Z","timestamp":1548187869000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-12-134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,25]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["672"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-12-134","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,25]]},"article-number":"134"}}